Kimaritec
Woolloongabba, United States
Kimaritec is developing new therapies for cancer, by manipulating the body’s protein recycling pathway to drive protein degradation of critical oncoproteins. Cancer remains a disease with high unmet medical need, with many patients succumbing to tumours which become unresponsive to current therapy. Clinicians and patients are looking for new approaches to eradicate or slow progression of cancer. Kimaritec is taking a novel approach to selectively degrade proteins important for cancer growth and metastasis. It is hoped that by harnessing this novel the protein degradation pathway, Kimaritec will develop new anti-cancer therapies.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- au.linkedin.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Kimaritec?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now